By Professor Naresh Kumar

Preprints

Ng SW; Gadde S; Chung N-Y; Wang Q; Doughty L; Nero TL; Jayatilleke N; Seneviratne J; Carter DR; Mateos MK; Tsoli M; Ziegler DS; Endersby R; Kumar N; Chesler L; Liu T; Parker MW; Cheung BB; Marshall GM, 2026, Therapeutic targeting of MYC- and MYCN-driven medulloblastoma with a novel MYC degrader molecule, http://dx.doi.org/10.64898/2026.07.09.737604

Gautam S; Mawari G; Daga MK; Kumar N, 2021, A case report on uneventful anticoagulation and persistence of type1 respiratory failure post severe COVID-19 infection in a patient of Osler-Weber-Rendu Syndrome., http://dx.doi.org/10.21203/rs.3.rs-941184/v1

Urmi UL; Attard S; Vijay AK; Willcox MDP; Kumar N; Islam S; Kuppusamy R, Antiviral Activity of Anthranilamide Peptidomimetics against Herpes Simplex Virus 1 and a Coronavirus, http://dx.doi.org/10.20944/preprints202308.2017.v1

Daga MK; Mawari G; Wasi S; Kumar N; Sharma U; Hussain M, Current Pattern and Clinico-Bacteriological Profile of Healthcare Associated Infections (HAI) in an ICU Setting: An Observational Study, http://dx.doi.org/10.21203/rs.3.rs-874099/v1

Grunfeld DA; Jones AM; Sun J; Le ST; Pickford R; Huang Q; Manefield M; Kumar N; Lee M; O’Carroll D, Electrochemical Degradation of a Perfluoroalkyl Substance (Pfas) Using a Simple Activated Carbon Cathode, http://dx.doi.org/10.2139/ssrn.4203122

Gantier M; Ullah T; Johansen M; Balka K; Ambrose R; Gearing L; Wenholz D; Zeng J; Miemczyk S; Nguyen D; Venkatraman R; Dennis M; Alharbi A; Ellyard J; Wong W; Kile B; Vinuesa C; Kelly G; Hansbro P; Laczka O; De Nardo D; Hansbro N; Kumar N, Pharmacological inhibition of TBK1/IKKε blunts COVID-19 immunopathology, http://dx.doi.org/10.21203/rs.3.rs-1336801/v1

Gadde S; Kleynhans A; Holien J; Bhadbhade M; Nguyen PLD; Mittra R; Carter D; Marshall G; Cheung B; Kumar N, Pyrimido[1,2-A]Benzimidazoles as Inhibitors of Oncoproteins Ubiquitin Specific Protease 5 and MYCN in the Childhood Cancer Neuroblastoma, http://dx.doi.org/10.2139/ssrn.4283384

Back to profile page